IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference focuses on advancing scientific understanding of metabolic disorders, exploring cutting-edge diagnostic and therapeutic innovations, and facilitating interdisciplinary exchange. It addresses emerging trends in diabetes, endocrine pathophysiology, and metabolic disease mechanisms, aiming to enhance translational research, clinical management, and patient-centered outcomes.

EDEM 2026 serves as a premier international platform for diabetologists, endocrinologists, researchers, and healthcare professionals to advance scientific knowledge, exchange innovative ideas, and foster interdisciplinary collaboration. The conference brings together leading experts, early-career researchers, and clinical practitioners to explore the latest developments in diabetes, endocrine disorders, and metabolic disease management.

The conference will cover a broad spectrum of topics, including metabolic regulation, obesity and weight management, cardiovascular risk, novel therapeutics, and emerging diagnostic technologies. By integrating clinical, translational, and experimental research, EDEM 2026 provides a comprehensive view of current challenges and future directions in diabetes and endocrinology.

Awards & Recognition:

The conference recognizes excellence through the Best Presenter, Innovative Researcher, Best Poster, and Best Young Researcher Awards, highlighting exceptional contributions and promoting innovation among students and early-career professionals, while providing a global platform to present and gain recognition for their research achievements.